AstraZeneca sells rights over two patented cancer drugs, South Korea introduces IP backed financing and more
The post analyses recent developments in patent and intellectual property, including AstraZeneca’s sale of rights to cancer drugs and South Korea’s new IP backed financing initiatives. It also…